# Efficacy of the Standard Treatment and Fusion Ontogenetic Surgery for Gynecologic Cancers

> **NCT02986568** · NA · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 380 (estimated)

## Conditions studied

- Cervical Cancer
- Uterine Cancer

## Interventions

- **PROCEDURE:** Cervical cancer
- **PROCEDURE:** Uterine cancer
- **PROCEDURE:** Cervical cancer, pelvic sidewall invasion
- **PROCEDURE:** Non-cervical cancer, pelvic sidewall invasion

## Key facts

- **NCT ID:** NCT02986568
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05-10
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 380 (ESTIMATED)
- **Last updated:** 2020-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02986568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02986568, "Efficacy of the Standard Treatment and Fusion Ontogenetic Surgery for Gynecologic Cancers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02986568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*